Benzoxazinone derivative

Details Benzoxazinone derivative Benzoxazinone derivative

C - Chemistry, Metallurgy

07

D

C07D 239/80 (2006.01) A61K 31/517 (2006.01) A61K 31/536 (2006.01) A61P 1/00 (2006.01) A61P 1/04 (2006.01) A61P 1/10 (2006.01) A61P 1/16 (2006.01) A61P 1/18 (2006.01) A61P 3/00 (2006.01) A61P 3/04 (2006.01) A61P 3/06 (2006.01) A61P 3/10 (2006.01) A61P 3/12 (2006.01) A61P 5/00 (2006.01) A61P 5/24 (2006.01) A61P 9/00 (2006.01) A61P 9/04 (2006.01) A61P 9/06 (2006.01) A61P 9/10 (2006.01) A61P 9/12 (2006.01) A61P 11/00 (2006.01) A61P 13/12 (2006.01) A61P 15/00 (2006.01) A61P 15/08 (2006.01) A61P 15/10 (2006.01) A

Patent

CA 2701406

[PROBLEMS] To provide a compound useful as an agent for the treatment of circulatory diseases, nervous system diseases, metabolic diseases, reproductive system diseases, and digestive tract diseases. [MEANS FOR SOLVING PROBLEMS] The compound, which is for use as an active ingredient, is represented by the formula (I): (see formula I) [wherein R1 represents optionally halogenated C1-6 alkyl, etc.; R2 represents, e.g., a group represented by the formula (II-I) or (II-4) (see formula II-1 see formula II-4) (wherein W represents C1-6 alkylene, etc. and R represents C1-6 alkyl, etc.); R3 represents hydrogen, C1-6 alkyl, etc.; X represents -O-, -NH-, etc.; and Y1, Y2, Y3, and Y4 each independently represents -CH-, -N-, etc.].

L'invention a pour objectif de proposer un composé utile comme agent pour le traitement de maladies circulatoires, de maladies du système nerveux, de maladies métaboliques, de maladies du système reproducteur et de maladies du tractus digestif. À cet effet, le composé destiné à être utilisé comme ingrédient actif est représenté par la formule (I) : [dans laquelle R1 représente alkyle en C1-6 facultativement halogéné, etc.; R2 représente, par exemple, un groupe représenté par la formule (II-1) ou (II-4) (dans laquelle W représente alkylène en C1-6, etc. et R représente alkyle en C1-6, etc.); R3 représente hydrogène, alkyle en C1-6, X représente -O-, -NH-, etc.; et Y1, Y2, Y3 et Y4 représentent chacun indépendamment -CH-, -N-, etc.].

Affiliated with

Also associated with

Rating

Benzoxazinone derivative does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Benzoxazinone derivative, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzoxazinone derivative will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1822425